$URGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UroGen Pharma Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in UroGen Pharma Ltd.. Get notifications about new insider transactions in UroGen Pharma Ltd. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28 2019 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | M | 4.02 | 128,000 | 514,560 | 0 | |
| Mar 28 2019 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Buy | M | 4.02 | 128,000 | 514,560 | 212,211 | 84.2 K to 212.2 K (+152.00 %) |
| Mar 22 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | P | 37.01 | 272 | 10,066 | 4,610 | 4.3 K to 4.6 K (+6.27 %) |
| Mar 22 2019 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | M | 16.99 | 15,000 | 254,850 | 25,000 | |
| Mar 22 2019 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Buy | M | 16.99 | 15,000 | 254,850 | 15,000 | 0 to 15 K |
| Mar 07 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,042 | 0 | 7,292 | |
| Mar 07 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 37.30 | 1,991 | 74,264 | 4,338 | 6.3 K to 4.3 K (-31.46 %) |
| Mar 07 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,042 | 0 | 6,329 | 5.3 K to 6.3 K (+19.71 %) |
| Mar 07 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,034 | 0 | 14,073 | |
| Mar 07 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 37.30 | 2,804 | 104,589 | 4,230 | 7 K to 4.2 K (-39.86 %) |
| Mar 07 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 7,034 | 0 | 7,034 | 0 to 7 K |
| Jan 29 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 29 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 42.50 | 15,000 | 637,500 | 15,000 | |
| Jan 29 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 29 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 42.50 | 15,000 | 637,500 | 15,000 | |
| Jan 29 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| Jan 29 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | A | 42.50 | 7,500 | 318,750 | 7,500 | |
| Jan 09 2019 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 0.00 | 317,065 | 0 | 317,065 | |
| Jan 09 2019 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 47.57 | 277,432 | 13,197,440 | 277,432 | |
| Jan 09 2019 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 0.00 | 317,065 | 0 | 317,065 | |
| Jan 09 2019 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 47.57 | 277,432 | 13,197,440 | 277,432 | |
| Nov 29 2017 | URGN | UroGen Pharma Ltd. | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 40.51 | 177,807 | 7,202,962 | 1,242,031 | 1.4 M to 1.2 M (-12.52 %) |
| Nov 29 2017 | URGN | UroGen Pharma Ltd. | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 41.12 | 31,491 | 1,294,910 | 1,419,838 | 1.5 M to 1.4 M (-2.17 %) |